Development of High-Titer Antidrug Antibodies in a Phase 1b/2a Infant Clesrovimab Trial Are Associated With RSV Exposure Beyond Day 150
Carmen Sofia Arriola, Antonios O. Aliprantis, Jia Yao Phuah, Radha Railkar et al.
Citations
10 citations
Journal
The Journal of Infectious Diseases
Topics
Viral Infections and Immunology Research
Field-Weighted Citation Impact (FWCI)
4.02
article
Development of High-Titer Antidrug Antibodies in a Phase 1b/2a Infant Clesrovimab Trial Are Associated With RSV Exposure Beyond Day 150
Carmen Sofia Arriola, Antonios O. Aliprantis, Jia Yao Phuah, Radha Railkar, Lori M Tobias, Nithya Thambi, Ryan P. Staupe, Yu Cao, Kalpit A. Vora, Troy W. McKelvey, Brian M. Maas